Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Felicia Ceban, Mehala Subramaniapillai, Joshua D. Rosenblat, Rodrigo B. Mansur & Roger S. McIntyre. (2023) Can COVID-19 have a clinically significant effect on drug metabolism?. Expert Opinion on Drug Safety 22:1, pages 1-3.
Read now
Read now
Kristina Jonsson-Schmunk, Romi Ghose & Maria A. Croyle. (2021) Immunization and Drug Metabolizing Enzymes: Focus on Hepatic Cytochrome P450 3A. Expert Review of Vaccines 20:5, pages 623-634.
Read now
Read now
Articles from other publishers (30)
Huiqiong Zou, Peipei Hao, Yingying Cao, Li Li, Ruifeng Ding, Xuefeng Bai & Yongzhi Xue. (2023) Hippophae rhamnoides reverses decreased CYP2D6 expression in rats with BCG-induced liver injury. Scientific Reports 13:1.
Crossref
Crossref
Rahul Kumar Vishwakarma, Devendra Singh Negi & Aaysha Negi. (2023) Abortitristoside A and desrhamnosylverbanscoside: the potential COX-2 inhibitor from the leaves of Nyctanthes arbor-tristis as anti-inflammatory agents based on the in vitro assay, molecular docking and ADMET prediction. Chemical Papers 77:6, pages 3035-3049.
Crossref
Crossref
Jianchun Zhao, Wenmin Yuan, Shixiao Wang, Hongwei Zhang, Dan Chen, Xiaochen Niu, Xiaochun Liu, Li Liu & Jiangming Gao. (2022) Comparative Pharmacokinetics and Tissue Distribution of M10 and Its Metabolite Myricetin in Normal and Dextran-Sodium-Sulfate-Induced Colitis Mice. Molecules 27:23, pages 8140.
Crossref
Crossref
Rahul Kumar Vishwakarma, Aaysha Negi & Devendra Singh Negi. (2022) Development of potential COX inhibitor as anti-inflammatory agents from leaves of Lantana camara by in-vitro analysis, molecular docking and ADMET prediction. Journal of the Indian Chemical Society 99:10, pages 100694.
Crossref
Crossref
C. Michael White, Dakota J. Sicignano & Kimberly Smith. (2021) Impact of Interferons and Biological Drug Inhibitors of IL-2 and IL-6 on Small-Molecule Drug Metabolism Through the Cytochrome P450 System. Annals of Pharmacotherapy 56:2, pages 170-180.
Crossref
Crossref
Rahul Kumar Vishwakarma, Aaysha Negi & Devendra Singh Negi. (2022) Anti-oxidant, COX inhibition activity of different extract of bark of Betula utilis and molecular docking analysis of its phytochemicals against COX-1 and COX-2 isoenzyme. Materials Today: Proceedings 57, pages 251-258.
Crossref
Crossref
Bernhard Texler, Andreas Zollner, Vera Reinstadler, Simon J. Reider, Sophie Macheiner, Barbara Jelusic, Alexandra Pfister, Christina Watschinger, Nicole Przysiecki, Herbert Tilg, Herbert Oberacher & Alexander R. Moschen. (2022) Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic Pharmacokinetics. Cellular and Molecular Gastroenterology and Hepatology 13:2, pages 383-404.
Crossref
Crossref
Azka Yaqoob, Qudsia Rehman, Kanwal Rehman, Muhammad Sajid Hamid Akash, Iqbal Hussain & Rasheed Ahmad. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
73
108
.
Varsha Komalla, Mehra Haghi & Veysel Kayser. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
493
521
.
Camille Lenoir, Amine Niederer, Victoria Rollason, Jules Alexandre Desmeules, Youssef Daali & Caroline Flora Samer. (2021) Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics. CPT: Pharmacometrics & Systems Pharmacology 11:1, pages 30-43.
Crossref
Crossref
Daniela Fanni, Federica Pinna, Clara Gerosa, Pasquale Paribello, Bernardo Carpiniello, Gavino Faa & Mirko Manchia. (2021)
Anatomical distribution and expression of
CYP
in humans: Neuropharmacological implications
. Drug Development Research 82:5, pages 628-667.
Crossref
Crossref
Inès Ben Ghezala, Maëva Charkaoui, Christophe Michiels, Marc Bardou & Maxime Luu. (2021) Small Molecule Drugs in Inflammatory Bowel Diseases. Pharmaceuticals 14:7, pages 637.
Crossref
Crossref
Lucy Darakjian, Malavika Deodhar, Jacques Turgeon & Veronique Michaud. (2021) Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity. International Journal of Molecular Sciences 22:9, pages 4967.
Crossref
Crossref
Jiayi Yin, Fengcheng Li, Ying Zhou, Minjie Mou, Yinjing Lu, Kangli Chen, Jia Xue, Yongchao Luo, Jianbo Fu, Xu He, Jianqing Gao, Su Zeng, Lushan Yu & Feng Zhu. (2021) INTEDE: interactome of drug-metabolizing enzymes. Nucleic Acids Research 49:D1, pages D1233-D1243.
Crossref
Crossref
Ilaria Campesi, Andrea Montella & Flavia Franconi. (2021) Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’. Pharmacological Research 163, pages 105285.
Crossref
Crossref
Armanda V. Rodrigues, Graça Alexandre-Pires, Ana Valério-Bolas, David Santos-Mateus, Mariana Rafael-Fernandes, Maria A. Pereira, Dário Ligeiro, Telmo Nunes, Raquel Alves-Azevedo, Marcos Santos, Isabel Pereira da Fonseca & Gabriela Santos-Gomes. (2020) 3D-Hepatocyte Culture Applied to Parasitology: Immune Activation of Canine Hepatic Spheroids Exposed to Leishmania infantum. Biomedicines 8:12, pages 628.
Crossref
Crossref
Maud Maillard, Christine Chevreau, Félicien Le Louedec, Manon Cassou, Caroline Delmas, Laure Gourdain, Jean-Yves Blay, Didier Cupissol, Emmanuelle Bompas, Antoine Italiano, Nicolas Isambert, Corinne Delcambre-Lair, Nicolas Penel, François Bertucci, Cécile Guillemet, Julien Plenecassagnes, Stéphanie Foulon, Étienne Chatelut, Axel Le Cesne & Fabienne Thomas. (2020) Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma. Cancers 12:12, pages 3647.
Crossref
Crossref
Fangle Liu, Qiuyu Zhang, Chaozhan Lin, Yufeng Yao, Meiqi Wang, Changhui Liu & Chenchen Zhu. (2020) A comparative study on pharmacokinetics and tissue distribution of 5-hydroxy-4-methoxycanthin-6-one and its metabolite in normal and dextran sodium sulfate-induced colitis rats by HPLC-MS/MS. Journal of Pharmacy and Pharmacology 72:12, pages 1761-1770.
Crossref
Crossref
Yazun Jarrar, Amin Al-Doaiss, Mohammad Alfaifi, Ali Shati, Mohammed Al-Kahtani & Bashir Jarrar. (2020) The influence of five metallic nanoparticles on the expression of major drug-metabolizing enzyme genes with correlation of inflammation in mouse livers. Environmental Toxicology and Pharmacology 80, pages 103449.
Crossref
Crossref
Sophie L. Penman, Robyn T. Kiy, Rebecca L. Jensen, Christopher Beoku‐Betts, Ana Alfirevic, David Back, Saye H. Khoo, Andrew Owen, Munir Pirmohamed, B. Kevin Park, Xiaoli Meng, Christopher E. Goldring & Amy E. Chadwick. (2020) Safety perspectives on presently considered drugs for the treatment of COVID‐19. British Journal of Pharmacology 177:19, pages 4353-4374.
Crossref
Crossref
Gary Berman, Robert Croop, David Kudrow, Philip Halverson, Meghan Lovegren, Alexandra C. Thiry, Charles M. Conway, Vladimir Coric & Richard B. Lipton. (2020) Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine. Headache: The Journal of Head and Face Pain 60:8, pages 1734-1742.
Crossref
Crossref
Shetty Ravi Dyavar, Timothy M. Mykris, Lee C. Winchester, Kimberly K. Scarsi, Courtney V. Fletcher & Anthony T. Podany. (2020) Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics. Scientific Reports 10:1.
Crossref
Crossref
Navid Neyshaburinezhad, Mohammadreza Rouini, Nooshin Shirzad, Alireza Esteghamati, Manouchehr Nakhjavani, Soha Namazi & Yalda H. Ardakani. (2020) Evaluating the effect of type 2 diabetes mellitus on CYP450 enzymes and P-gp activities, before and after glycemic control: A protocol for a case–control pharmacokinetic study. MethodsX 7, pages 100853.
Crossref
Crossref
Jonathan Wang, Nirmalya Tripathy & Eun Ji Chung. (2020) Targeting and therapeutic peptide-based strategies for polycystic kidney disease. Advanced Drug Delivery Reviews 161-162, pages 176-189.
Crossref
Crossref
Sylvie M. Mimche, Choon-myung Lee, Ken H. Liu, Patrice N. Mimche, R. Donald Harvey, Thomas J. Murphy, Beatrice A. Nyagode, Dean P. Jones, Tracey J. Lamb & Edward T. Morgan. (2019) A non-lethal malarial infection results in reduced drug metabolizing enzyme expression and drug clearance in mice. Malaria Journal 18:1.
Crossref
Crossref
Huaqiao Tang, Min Xu, Jie Luo, Ling Zhao, Gang Ye, Fei Shi, Cheng Lv, Helin Chen, Yanyan Wang & Yinglun Li. (2019) Liver toxicity assessments in rats following sub-chronic oral exposure to copper nanoparticles. Environmental Sciences Europe 31:1.
Crossref
Crossref
Guncha Taneja, Suman Maity, Weiwu Jiang, Bhagavatula Moorthy, Cristian Coarfa & Romi Ghose. (2019) Transcriptomic profiling identifies novel mechanisms of transcriptional regulation of the cytochrome P450 (Cyp)3a11 gene. Scientific Reports 9:1.
Crossref
Crossref
Hans F. Merk. (2018) Toxische Effekte vermeiden. Der Deutsche Dermatologe 66:12, pages 924-932.
Crossref
Crossref
Min Xu, Huaqiao Tang, XueRong Zhou, Helin Chen, Qi Dong, Yuanli Zhang, Gang Ye, Fei Shi, Cheng Lv, Bo Jing, Changliang He, Ling Zhao & Yinglun Li. (2018) Effects and mechanisms of sub-chronic exposure to copper nanoparticles on renal cytochrome P450 enzymes in rats. Environmental Toxicology and Pharmacology 63, pages 135-146.
Crossref
Crossref
Huaqiao Tang, Min Xu, Fei Shi, Gang Ye, Cheng Lv, Jie Luo, Ling Zhao & Yinglun Li. (2018) Effects and Mechanism of Nano-Copper Exposure on Hepatic Cytochrome P450 Enzymes in Rats. International Journal of Molecular Sciences 19:7, pages 2140.
Crossref
Crossref